Theoretically, disrupting any step in the process from their biogenesis in tumor cells to internalization by recipient cells can successfully result in TDE dysregulation, such as inhibiting TDE biogenesis and packaging, modulating TDE trafficking, and blocking TDE internalization (184). The gene discussed is SERINC3; the disease is neoplasm.